Sign in

Private company

Axcella Health (United States)

Logo: axcellahealth.com3

American biological products company based in Cambridge, founded in 20081

In its 2023 annual report the company says: “We are a clinical-stage biotechnology company focused on pioneering a new approach to treat complex diseases using compositions of endogenous metabolic modulators, or EMMs. Our product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with the goal of simultaneously impacting multiple biological pathways.”65

Last updated Oct 21, 2026.

Overview

2008Founded1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersCambridge1
  • Websitewww.axcellahealth.com
  • Incorporated inDE4
  • Business address840 Memorial Drive, Third Floor, Cambridge, Ma 021394
  • Filer category, Emerging growth company4
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income5678-$77.0M in 2022+127% since 2018
-$80.0M-$60.0M-$40.0M-$20.0M02018: -$33.9M-$33.9M20182019: -$57.4M-$57.4M2019+69%2020: -$53.8M-$53.8M2020−6%2021: -$61.8M-$61.8M2021+15%2022: -$77.0M-$77.0M2022+24%
Net income5678-$81.2M in 2022+38% since 2017
-$100.0M-$75.0M-$50.0M-$25.0M02017: -$59.0M-$59.0M20172018: -$36.1M-$36.1M2018−39%2019: -$59.0M-$59.0M2019+64%2020: -$56.5M-$56.5M2020−4%2021: -$64.6M-$64.6M2021+14%2022: -$81.2M-$81.2M2022+26%
Fiscal year2017201820192020202120222023
Research and development$25.5M5$41.7M6$37.0M7$43.1M8$57.0M8
Operating expenses$61.8M8$77.0M8
Operating income-$33.9M5-$57.4M6-$53.8M7-$61.8M8-$77.0M8
Interest$2.8M5$3.4M5$2.9M8$3.0M8
Net income-$59.0M5-$36.1M5-$59.0M6-$56.5M7-$64.6M8-$81.2M8
Earnings per share-$1.787-$1.708-$1.498
Earnings per share (diluted)-$1.787-$1.708-$1.498
Shares (weighted, basic)38.1M shares854.4M shares8
Shares (weighted, diluted)38.1M shares854.4M shares8

Compare Axcella Health (United States) with another company

Corporate structure

Axcella Health (United States) sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Axcella Health (United States)

  • FMR LLC Filed SC 13G/A on Axcella Health (United States), latest Sep 11, 2023 (3 filings since Feb 9, 2022)
  • HarbourVest Partners L.P. Filed SC 13G/A on Axcella Health (United States), latest Feb 14, 2023 (2 filings since Mar 29, 2022)
  • Societe des Produits Nestle S.A. Filed SC 13G/A on Axcella Health (United States), latest Feb 2, 2023
  • Flagship VentureLabs IV, LLC Filed SC 13D/A on Axcella Health (United States), latest Oct 17, 2022 (3 filings since Mar 18, 2022)
  • Axcella Health (United States) Cambridge

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Axcella Health (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$4.5M8 Dec 31, 2022$4.3M8 Dec 31, 2021+5.5%
Accumulated depreciation$3.8M8 Dec 31, 2022$3.4M8 Dec 31, 2021+12.2%
Property and equipment, net$693.0K8 Dec 31, 2022$870.0K8 Dec 31, 2021−20.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$17.1M8 Dec 31, 2022$23.6M8 Dec 31, 2021−27.3%
Marketable securities, current$08 Dec 31, 2022$31.5M8 Dec 31, 2021−100.0%

Leadership

Who has led Axcella Health (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. William Hinshaw2019–2023

President

  1. William Hinshaw2019–2023
  2. Alison D. Schecter2021–2022

Chief financial officer

  1. Thomas Leggett2019
  2. Laurent Chardonnet2019–2021
  3. Robert Crane2022
2010201520202025
Board members and other officers (25)

Former names

  • Pronutria Biosciences, Inc.Feb 17, 2015 to Feb 24, 20164

Timeline

  1. Dec 22, 20238-K Regulation FD disclosure40
  2. Dec 19, 20238-K Completed an acquisition or sale41
  3. Dec 4, 20238-K Shareholder vote42
  4. Nov 17, 20238-K Listing notice or transfer43
  5. Nov 9, 20238-K Listing notice or transfer44
  6. Nov 1, 20238-K Executive or director change; Other events45
  7. Oct 6, 20238-K Listing notice or transfer; Other events46
  8. Sep 18, 20238-K Bylaws or fiscal year changed47
  9. Sep 14, 20238-K Regulation FD disclosure48
  10. Sep 11, 20238-K Shareholder vote49
  11. Aug 29, 20238-K Regulation FD disclosure50
  12. Aug 4, 20238-K Director nominations51
  13. May 8, 2019New chief executive William Hinshaw becomes CEO11
  14. 2008Founded Founded1

Calendar

When it reported results

  1. Aug 3, 2023Reported quarterly or annual results52
  2. May 4, 2023Reported quarterly or annual results53
  3. Mar 30, 2023Reported quarterly or annual results54
  4. Nov 1, 2022Reported quarterly or annual results55
  5. Aug 12, 2022Reported quarterly or annual results56
  6. May 5, 2022Reported quarterly or annual results57
  7. Mar 30, 2022Reported quarterly or annual results58
  8. Nov 10, 2021Reported quarterly or annual results59

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

115 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 36 major events, 50 insider forms, 9 large holders, 1 private raises, 11 other. The latest 20:

  1. Dec 22, 20238-K EDGAR
  2. Dec 19, 20238-K EDGAR
  3. Dec 4, 20238-K EDGAR
  4. Nov 17, 20238-K EDGAR
  5. Nov 17, 2023S-8 POS EDGAR
  6. Nov 17, 2023S-8 POS EDGAR
  7. Nov 17, 2023DEF 14A EDGAR
  8. Nov 9, 20238-K EDGAR
  9. Nov 6, 2023PRE 14A EDGAR
  10. Nov 1, 20238-K EDGAR
  11. Oct 6, 20238-K EDGAR
  12. Sep 18, 20238-K EDGAR
  13. Sep 14, 20238-K EDGAR
  14. Sep 11, 20238-K EDGAR
  15. Sep 11, 2023SC 13G/A EDGAR
  16. Aug 29, 20238-K EDGAR
  17. Aug 18, 2023ARS EDGAR
  18. Aug 18, 2023DEF 14A EDGAR
  19. Aug 7, 2023PRE 14A EDGAR
  20. Aug 4, 20238-K EDGAR

The 115 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

15 open-market trades by officers, directors and large owners since October 2021: 8 buys and 7 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 1, 2023Koziel MargaretChief Medical OfficerSale679$0.58$394Form 4
Feb 10, 2023Fehlner PaulSVP & Chief Legal OfficerSale5,221$0.66$3.4KForm 4
Oct 19, 2022Hinshaw WilliamPresident & CEOSale16,000$1.56$25.0KForm 4
Oct 13, 2022Flagship Ventures Opportunities Fund I General Partner LLC10% ownerBuy10,383,760$1.64$17.0MForm 4
Oct 13, 2022Societe des Produits Nestle S.A.10% ownerBuy3,658,536$1.64$6.0MForm 4
Sep 6, 2022Koziel MargaretChief Medical OfficerSale547$2.52$1.4KForm 4
Jun 1, 2022Koziel MargaretChief Medical OfficerSale590$2.01$1.2KForm 4
Mar 16, 2022Hinshaw WilliamPresident & CEOBuy13,089$1.91$25.0KForm 4
Mar 16, 2022Fehlner PaulSVP & Chief Legal OfficerBuy10,471$1.91$20.0KForm 4
Mar 16, 2022Epstein David RDirectorBuy26,178$1.91$50.0KForm 4
Mar 16, 2022Crane RobertChief Financial OfficerBuy39,267$1.91$75.0KForm 4
Mar 16, 2022Flagship Ventures Opportunities Fund I General Partner LLC10% ownerBuy6,319,371$1.91$12.1MForm 4
Mar 16, 2022Societe des Produits Nestle S.A.10% ownerBuy3,141,361$1.91$6.0MForm 4
Mar 1, 2022Koziel MargaretChief Medical OfficerSale553$1.86$1.0KForm 4
Jan 31, 2022Hinshaw WilliamPresident & CEOSale16,590$1.65$27.4KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$6.0M 2022–2022
Money received by yearMoney received by year, 2022–2022: $6.0M in all. Private raises (Form D) $6.0M.$0$2M$4M$6M2022 · Private raises (Form D): $6.0M2022
Figures by year
YearPrivate raises (Form D)Total
2022$6.0M$6.0M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Sep 20, 2022Raised $6 million in a private offering of debt64 Form D: $12 million offered in all Form D

SEC filer profile

How Axcella Health (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAxcella Health Inc.2
  • CIK0001633070
  • Filer status<br>emerging growth company2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)2
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance2
  • Business address840 Memorial Drive, Third Floor, Cambridge, MA 021392
  • Phone617-868-09492
  • Shares outstanding73,692,745 as of Jul 28, 202310
  • Public float$67.8M as of Jun 30, 20228
  • On EDGAR sinceFeb 17, 20152
  • Filings294 in all: 4 (112), 8-K (58), 3 (31), 10-Q (14), SC 13G/A (11), CORRESP (7), DEF 14A (5), SC 13G (5)2
    All 31 form types

    10-K (4), D/A (4), DEFA14A (4), UPLOAD (4), 424B5 (3), D (3), EFFECT (3), SC 13D/A (3), 424B4 (2), DRS (2), PRE 14A (2), S-1 (2), S-1/A (2), S-8 (2), S-8 POS (2), SC 13D (2), 25-NSE (1), 8-A12B (1), ARS (1), CERT (1), DRS/A (1), DRSLTR (1), S-3 (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2023
    Quarterly report (10-Q) Aug 3, 2023
    Proxy statement (DEF 14A) Nov 17, 2023
    Latest 8-K (8-K) Dec 22, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65